Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

CryoPort Names Stephen Wasserman To Board - Quick Facts

CryoPort, Inc. (CYRX.OB) on Thursday said it has named Stephen Wasserman, 65, to its Board of Directors. He replaces Carlton Johnson, who resigned from the Board earlier this month.

CryoPort provides cold chain frozen shipping systems primarily to the biotechnology, pharmaceutical, and life science industries. Wasserman has over 30 years of senior operating and financial management experience in the medical device and healthcare industries.

Wasserman is currently on the Board of the medical diagnostics firm Iris International and serves as chairman of the compensation committee.

Previously he was group vice president of the Diagnostic Systems Products division of medical technology firm Olympus America as well as a member of the executive committee for American Operations.

Larry Stambaugh, CryoPort's chairman and chief executive officer, said, "Stephen's experience managing highly successful medical device and diagnostic companies will be extremely valuable to CryoPort as we accelerate our commercial activities this year. We look forward to drawing on Stephen's in-depth knowledge of our target markets and his proven ability to drive the introduction of new technologies and products."

Register
To receive FREE breaking news email alerts for CryoPort Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Toyota Motor Corp. (TM, TYT.L) Thursday announced 1.1 percent decline in worldwide production for October, as there was a sharp decline in production of passenger cars in Japan. Production outside Japan improved 2.3 percent. In a separate announcement, the Japanese automaker said it will recall more... Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.